COVID-19 pandemic has created new problems and compounded existing ones faced by the global clinical research community. Without physical access to patients, the impact on data collection and patient monitoring has been significant and has forced an industry-wide initiative to re-evaluate how to manage clinical trials in this new paradigm.
In a recent industry survey, Oracle Health Sciences, in partnership with Informa Research, sought to gather insight on the impact of the Covid-19 pandemic on clinical data collection and clinical operations.
This webinar will provide perspectives from a leading CRO in Europe, about the obscurity around the implementation of new regulations, and how they are dealing with this new paradigm. Through the market research you will gain insight into the rate of adoption to decentralized trials, the need for new collaborations, and what new strategies are being assessed to overcome and flourish in this new world.
Key Learning Objectives
- Clinical data collection in a pandemic situation
- Regulatory challenges and concerns regarding remote data collection
- Clinical operation readiness in this new world
- How CROs:
- Are managing clinical data collection in a pandemic
- Dealing with regulatory challenges
- Preparing for clinical operational readiness in this new world
Audience
- Clinical operations and innovations
- Professionals seeking further knowledge on how to develop their digital strategy for clinical trials
- Director
- VP level
- Executive management
